Atlantic Equities Reiterates Overweight on IDEXX Laboratories, Maintains $600 Price Target
Portfolio Pulse from richadhand@benzinga.com
Atlantic Equities analyst Steve Chesney has reiterated an 'Overweight' rating on IDEXX Laboratories (NASDAQ:IDXX) and maintained a price target of $600.
August 04, 2023 | 10:49 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
IDEXX Laboratories has received an 'Overweight' rating from Atlantic Equities, with a maintained price target of $600.
The 'Overweight' rating from Atlantic Equities indicates a positive outlook for IDEXX Laboratories. This could potentially attract more investors, driving the stock price up in the short term. The maintained price target of $600 also shows confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100